Research trends and hotspots of liposomal bupivacaine: a bibliometric analysis from 2000 to 2025.
- 1Department of Anesthesiology, Sinopharm Dongfeng General Hospital Affiliated to Hubei University of Medicine, Shiyan, Hubei, China.
- 2Department of Breast and Thyroid Surgery, Sinopharm Dongfeng General Hospital Affiliated to Hubei University of Medicine, Shiyan, Hubei, China.
- 3The First Clinical Medical College, Gannan Medical University, Ganzhou, Jiangxi, China.
Abstract
Background
Postoperative pain remains a persistent challenge in perioperative care, frequently contributing to delayed patient mobilization, hindered functional recovery, and increased opioid consumption. Liposomal bupivacaine was developed to extend the release duration of local anesthetics following a single-dose administration; however, its clinical utility exhibits considerable variability across surgical procedures, block techniques, and comparator regimens. From a bibliometric perspective, this study aims to systematically investigate the overall developmental trajectory, intellectual structure, and emerging research frontiers of liposomal bupivacaine.Methods
A comprehensive literature search was performed in the Web of Science and Scopus databases for studies on liposomal bupivacaine published between 2000 and 2025. After deduplicating and merging records from both databases using a custom script, the consolidated dataset was analyzed using VOSviewer, CiteSpace, and the Bibliometrix R package.Results
A total of 3,552 publications were included in this study. The annual publication volume increased markedly between 2020 and 2025, reaching its peak in 2025. In terms of geographical and institutional distribution, the United States dominated the field, ranking first with 2,075 publications and 63,218 total citations; China ranked second with 565 publications, though its international co-authorship rate was only 13.23%. Major contributions were made by leading institutions such as the Mayo Clinic. At the author level, De Paula demonstrated the highest publication output and network betweenness centrality, Urman recorded the highest average citations per paper, and Onel accumulated the highest total citations; collectively, these three scholars constituted the intellectual core of the field with the most prominent contributions. Regarding journal distribution, The Journal of Arthroplasty ranked first in productivity, whereas Advanced Drug Delivery Reviews garnered the highest cumulative citations, reflecting distinct emphases on clinical translation and basic pharmaceutical dissemination, respectively. Co-citation clustering identified five major thematic domains: arthroplasty, liposomal bupivacaine, fascial plane blocks, breast reconstruction, and local anesthetic delivery. "Extended-release bupivacaine" emerged as a core keyword characterized by high occurrence and high centrality. Concurrently, "erector spinae plane block" and "autologous breast reconstruction" have surged rapidly in recent years, demonstrating an ongoing thematic shift toward procedure-specific applications.Conclusion
This study represents the first quantitative bibliometric analysis of liposomal bupivacaine, revealing an evolutionary shift in research focus from early investigations centered on pharmacokinetics and formulation to diversified, procedure-specific clinical applications. Future studies should prioritize expanding international collaborative networks and further exploring emerging techniques, such as fascial plane blocks, across understudied surgical populations. This research roadmap provides directional guidance for investigators, clinicians, and funding agencies alike.
Related
- Global research trends and hotspots in blood-based biomarkers for Alzheimer’s disease: a bibliometric analysis
- A bibliometric review of hotspots and trends in exosome research over the past decade
- Research trends and hotspots in publications jointly addressing remimazolam and midazolam : A bibliometric analysis, 2016–2025
- Bibliometric analysis of VR interventions in cancer research based on multiple databases: mapping research hotspots and developmental trends
- Global research hotspots and trends of osteoporosis and osteoarthritis comorbidity from 2005 to 2025: a bibliometric and visualized analysis
BibTeX
@article{wang2026research,
title = {{Research trends and hotspots of liposomal bupivacaine: a bibliometric analysis from 2000 to 2025.}},
author = {Yining Wang and Ting Chen and Ying Zhang and Jingchao Kang and Mingdong Zhao and Duoqin Huang and Jinguo Yang},
journal = {Frontiers in medicine},
year = {2026},
month = oct,
doi = {10.3389/fmed.2026.1955952},
url = {https://europepmc.org/article/MED/42948121},
note = {CC BY},
}
RIS
TY - JOUR
TI - Research trends and hotspots of liposomal bupivacaine: a bibliometric analysis from 2000 to 2025.
AU - Yining Wang
AU - Ting Chen
AU - Ying Zhang
AU - Jingchao Kang
AU - Mingdong Zhao
AU - Duoqin Huang
AU - Jinguo Yang
PY - 2026
DA - 2026/10/13
JO - Frontiers in medicine
DO - 10.3389/fmed.2026.1955952
UR - https://europepmc.org/article/MED/42948121
AB - Background Postoperative pain remains a persistent challenge in perioperative care, frequently contributing to delayed patient mobilization, hindered functional recovery, and increased opioid consumption. Liposomal bupivacaine was developed to extend the release duration of local anesthetics following a single-dose administration; however, its clinical utility exhibits considerable variability across surgical procedures, block techniques, and comparator regimens. From a bibliometric perspective, this study aims to systematically investigate the overall developmental trajectory, intellectual structure, and emerging research frontiers of liposomal bupivacaine.Methods A comprehensive literature search was performed in the Web of Science and Scopus databases for studies on liposomal bupivacaine published between 2000 and 2025. After deduplicating and merging records from both databases using a custom script, the consolidated dataset was analyzed using VOSviewer, CiteSpace, and the Bibliometrix R package.Results A total of 3,552 publications were included in this study. The annual publication volume increased markedly between 2020 and 2025, reaching its peak in 2025. In terms of geographical and institutional distribution, the United States dominated the field, ranking first with 2,075 publications and 63,218 total citations; China ranked second with 565 publications, though its international co-authorship rate was only 13.23%. Major contributions were made by leading institutions such as the Mayo Clinic. At the author level, De Paula demonstrated the highest publication output and network betweenness centrality, Urman recorded the highest average citations per paper, and Onel accumulated the highest total citations; collectively, these three scholars constituted the intellectual core of the field with the most prominent contributions. Regarding journal distribution, The Journal of Arthroplasty ranked first in productivity, whereas Advanced Drug Delivery Reviews garnered the highest cumulative citations, reflecting distinct emphases on clinical translation and basic pharmaceutical dissemination, respectively. Co-citation clustering identified five major thematic domains: arthroplasty, liposomal bupivacaine, fascial plane blocks, breast reconstruction, and local anesthetic delivery. "Extended-release bupivacaine" emerged as a core keyword characterized by high occurrence and high centrality. Concurrently, "erector spinae plane block" and "autologous breast reconstruction" have surged rapidly in recent years, demonstrating an ongoing thematic shift toward procedure-specific applications.Conclusion This study represents the first quantitative bibliometric analysis of liposomal bupivacaine, revealing an evolutionary shift in research focus from early investigations centered on pharmacokinetics and formulation to diversified, procedure-specific clinical applications. Future studies should prioritize expanding international collaborative networks and further exploring emerging techniques, such as fascial plane blocks, across understudied surgical populations. This research roadmap provides directional guidance for investigators, clinicians, and funding agencies alike.
SN - 2296-858X
ER -